L Sighinolfi

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals

Dario Di Luca, Prisco Mirandola, Tullia Ravaioli et al. · Journal of Medical Virology · 1995 · 105 citations

Dentistry, Infectious Diseases, Microbiology +17

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral‐naïve patients

Paola Cicconi, Alessandro Cozzi‐Lepri, Antonella Castagna et al. · HIV Medicine · 2009 · 85 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy

Carlo Torti, Mattia Prosperi, Davide Motta et al. · Clinical Microbiology and Infection · 2011 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Open, Randomized, Multicentre Italian Trial on Peg-Ifn plus Ribavirin versus Peg-Ifn Monotherapy for Chronic Hepatitis C in HIV-Coinfected Patients on Haart

Antonietta Cargnel, Elena Angeli, Annalisa Mainini et al. · Antiviral Therapy · 2005 · 52 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16